Developing a three-year medium-term management plan starting in FY2027. By amending the articles of incorporation, the company plans to change the accounting period from June 30 to March 31. Segments will focus on new market development and new technology development in Radiation facilities-related and Life Sciences-related areas. The target for medium-term consolidated net sales is 1,962 million yen in FY2027, 3,400 million yen in FY2028, and 4,200 million yen in FY2029.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"3446","jir_company_name":"J-Tech Corporation","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-08-10","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/3446-20260810-02.pdf","jir_short_summary":"Developing a three-year medium-term management plan starting in FY2027. By amending the articles of incorporation, the company plans to change the accounting period from June 30 to March 31. Segments will focus on new market development and new technology development in Radiation facilities-related and Life Sciences-related areas. The target for medium-term consolidated net sales is 1,962 million yen in FY2027, 3,400 million yen in FY2028, and 4,200 million yen in FY2029.","jir_summary":"### Overview of the Medium-Term Management Plan\nJ-Tech Corporation announced, subject to approval at the ordinary general meeting of shareholders scheduled for September 29, 2026, its plan to change the current fiscal year-end to the end of March and disclosed a three-year consolidated medium-term plan starting from FY2027. In light of the previous year\u2019s consolidated results, which saw increased revenue but decreased profits, the company will pursue a growth strategy that balances stable growth of existing businesses with full-scale development of new businesses. Specifically, the company will focus on Radiation-related and Life Sciences-related businesses, driving market expansion and new technology development mainly in Asia.\n\n### Outlook and Segment Initiatives\nSegment-wise, the company will strengthen structures to meet demand for high-precision mirrors in Radiation facility-related areas, expanding in the Asian market and addressing upgrade demand in Europe. In Life Sciences, centered on automated culture devices, the company will accelerate labor-saving and autonomous operation, pursuing new market development. The subsidiary Electronic Science Co., Ltd. will drive the expansion of high-precision temperature measurement devices in the United States and prepare for the market introduction of hydrogen analysis equipment. In new businesses, the company will advance device development utilizing nano-surface processing technologies to capture demand for optical components in semiconductors and space sectors.","jir_financial_highlights":"Sales: 1,962 (FY2027)\nOperating income: 74 (FY2027)\nOrdinary income: 106 (FY2027)","jir_category":"","jir_hashtags":"#J-TechCorporation, #MediumTermManagementPlan, #BusinessStrategy, #Radiation, #LifeScience","jir_key_figures":"Sales FY2027: 1,962 million yen\nSales FY2028: 3,400 million yen\nSales FY2029: 4,200 million yen","jir_meta_title":"\u3010J-Tech Corporation\u3011Notice Regarding Medium-Term Management Plan Formulation | 2027-2029","jir_meta_description":"J-Tech Corporation announces its three-year medium-term management plan. This includes consideration of a change in fiscal year-end, and outlines growth strategies in Radiation and Life Sciences, with segment-by-segment targets.","jir_og_title":"J-Tech Corporation Publishes Medium-Term Plan | 2027-2029","jir_og_description":"Overview of the medium-term plan and segment strategies. Summary of potential fiscal year-end changes and growth measures for new businesses from an investor's perspective.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":59399,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"business_update","footnotes":""},"sector":[],"importance":[],"class_list":["post-100336","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n